Huawei's recently released Medical Technology Digitalization 2.0 Solution implements AI-assisted diagnosis and intelligent quality control, enabling precision healthcare and hierarchical diagnosis and treatment. The tech giant has also developed wearable devices using in-house systems and new hardware, aiming to help consumers build healthier lifestyles.
The company believes that the coming years present significant opportunities for digital and intelligent technologies to drive high-quality healthcare development.
To capitalize on this trend, Huawei is focusing on core technologies and offering scenario-specific solutions such as Smart Ward, Smart Hospital Campus, and Telemedicine. These initiatives aim to enhance operational efficiency and optimize services for the healthcare industry.
Recognizing that medical image data accounts for 80% of clinical data, Huawei has designed its Medical Technology Digitalization 2.0 Solution to integrate AI, computing, storage, and network technologies, providing AI-based quality control and diagnosis capabilities.
The solution enables intelligent segmentation, detection, and quantitative analysis of image data, achieving over 90% accuracy in AI quality control. This advancement effectively reduces missed diagnoses and shortens diagnostic times. Additionally, Huawei has introduced solutions to improve ultrasound diagnosis quality and efficiency.
On the consumer front, Huawei recently launched the new Watch GT 5 series featuring an advanced TruSense health system and, for the first time, a dedicated stress detection app. This expansion allows Huawei's health detection service to progress from focusing solely on physical health to encompassing mental well-being as well.
Furthermore, Huawei's Watch D2 stands out as the world's first smartwatch with ambulatory blood pressure monitoring. Certified by both NMPA and MDR, it offers medically certified health monitoring features.
